Lei Zhao

Lei Zhao

Chinese PLA General Hospital - Beijing / China
Others
AD Scientific Index ID: 4967952
中国PLA综合医院
person_outline Lei Zhao's MOST POPULAR ARTICLES
1-) Development of novel tetravalent anti-CD20 antibodies with potent antitumor activity B Li, S Shi, W Qian, L Zhao, D Zhang, S Hou, L Zheng, J Dai, J Zhao, ... Cancer research 68 (7), 2400-2408, 2008 952008
2-) Characterization of a rituximab variant with potent antitumor activity against rituximab-resistant B-cell lymphoma B Li, L Zhao, H Guo, C Wang, X Zhang, L Wu, L Chen, Q Tong, W Qian, ... Blood 114 (24), 5007-5015, 2009 862009
3-) Bispecific antibody to ErbB2 overcomes trastuzumab resistance through comprehensive blockade of ErbB2 heterodimerizationB Li, Y Meng, L Zheng, X Zhang, Q Tong, W Tan, S Hu, H Li, Y Chen, ...Cancer research 73 (21), 6471-6483, 2013782013
4-) A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivoJ Dai, B Li, J Shi, L Peng, D Zhang, W Qian, S Hou, L Zhao, J Gao, Z Cao, ...Cancer immunology, immunotherapy 59 (3), 355-366, 2010782010
5-) Suppression of Tumor Growth and Metastasis by Simultaneously Blocking Vascular Endothelial Growth Factor (VEGF)–A and VEGF-C with a Receptor-Immunoglobulin Fusion ProteinD Zhang, B Li, J Shi, L Zhao, X Zhang, C Wang, S Hou, W Qian, G Kou, ...Cancer research 70 (6), 2495-2503, 2010692010